Literature DB >> 23352102

Fertility in cancer patients after cryopreservation of one ovary.

K T Schmidt1, A Nyboe Andersen, T Greve, E Ernst, A Loft, C Yding Andersen.   

Abstract

This questionnaire study describes the fertility and ovarian function in 143 adult female cancer survivors with only one ovary due to cryopreservation of the other. The women were asked about their ovarian function (as defined by the presence of a spontaneous menstrual cycle), pregnancies and their outcome. The mean follow-up time was 58months after cryopreservation (range 24-129months). The risk of premature ovarian failure was high in the group of patients with leukaemia (13/15; 87%) but low in the breast cancer group (5/54; 9%). Fifty-seven women had actively tried to become pregnant after end of treatment; of these, 41 women obtained a total of 68 pregnancies resulting in 45 live births and five ongoing pregnancies, 15 spontaneous abortions, one ectopic pregnancy and two elective abortions. In the remaining 86 women without a pregnancy wish, there had been five elective abortions. Ninety-three per cent of the pregnancies were after natural conception and only four cases were a result of fertility treatment. The overall risk of premature ovarian failure was low (22%). Patients who retain their ovarian function after treatment of a malignant disease have a good chance of becoming pregnant.
Copyright © 2013 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23352102     DOI: 10.1016/j.rbmo.2012.12.001

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  7 in total

Review 1.  Fertility preservation in women with cancer.

Authors:  Michel De Vos; Johan Smitz; Teresa K Woodruff
Journal:  Lancet       Date:  2014-10-04       Impact factor: 79.321

2.  Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation.

Authors:  Gilad Karavani; Amihai Rottenstreich; Natali Schachter-Safrai; Adiel Cohen; Michael Weintraub; Tal Imbar; Ariel Revel
Journal:  BMC Womens Health       Date:  2021-05-13       Impact factor: 2.809

3.  A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.

Authors:  Joyce Chai; A Forbes Howie; David A Cameron; Richard A Anderson
Journal:  Eur J Cancer       Date:  2014-07-11       Impact factor: 9.162

Review 4.  Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives.

Authors:  Richard A Anderson; W Hamish B Wallace; Evelyn E Telfer
Journal:  Hum Reprod Open       Date:  2017-03-29

Review 5.  FertiPROTEKT, Oncofertility Consortium and the Danish Fertility-Preservation Networks - What Can We Learn From Their Experiences?

Authors:  Michael von Wolff; Claus Yding Andersen; Teresa K Woodruff; Frank Nawroth
Journal:  Clin Med Insights Reprod Health       Date:  2019-04-30

6.  Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro.

Authors:  Babak Asadi Azarbaijani; Mona Sheikhi; Irma C Oskam; Mirja Nurmio; Tiina Laine; Helena Tinkanen; Sirpa Mäkinen; Tom G Tanbo; Outi Hovatta; Kirsi Jahnukainen
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

7.  Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.

Authors:  P Rodrigues; M Marques; S Pimentel; M Rato; P Carvalho; S C Correia; N Mendes; H Amaral; J P Fernandes; M J Carvalho; C E Plancha
Journal:  J Assist Reprod Genet       Date:  2020-10-28       Impact factor: 3.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.